Investor profile
Parkwalk Advisors has backed 61 European tech companies across 91 funding rounds between 2011 and 2026, joining rounds totalling €859M. Most active in Healthtech and Software. Data as of 6 Aug 2026.
Also recorded as: Parkwalk · ParkWalk Advisors · Parkwalk Advisors Ltd
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Brainomix | UK | 5 | €69M |
| Paragraf | UK | 2 | €58M |
| GaN Devices | UK | 3 | €56M |
| Quantum Motion | UK | 1 | €48M |
| Phasecraft | UK | 2 |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Paragraf | Series B | €54M | 2022-03 |
| Quantum Motion | Series B | €48M | 2023-02 |
| Bramble Energy | Other | €42M | 2022-02 |
| moa Technology Limited |
| €44M |
| Bramble Energy | UK | 1 | €42M |
| moa Technology Limited | UK | 1 | €41M |
| PhoreMost | UK | 1 | €39M |
| Entia | UK | 3 | €39M |
| AccelerComm | UK | 2 | €38M |
| PetMedix | UK | 1 | €31M |
| Mogrify | UK | 2 | €24M |
| Yasa Motors | UK | 1 | €17M |
| Enhanced Genomics | UK | 1 | €16M |
| Oxbotica | UK | 1 | €16M |
| Congenica | UK | 1 | €15M |
| Mirriad | UK | 1 | €14M |
| DiffBlue | UK | 2 | €14M |
| Enhanc3D Genomics | UK | 1 | €11M |
| PredictImmune | UK | 1 | €11M |
| Orthox | UK | 1 | €11M |
| Scripta Therapeutics | UK | 1 | €10M |
| GeoSpock | UK | 2 | €10M |
| Pathfinder Medical | UK | 1 | €10M |
| Wayland Additive | UK | 2 | €10M |
| GripAble | UK | 1 | €10M |
| Charco Neurotech | UK | 1 | €8.8M |
| Fluidic Analytics | UK | 2 | €8.2M |
| Horizon Discovery | UK | 1 | €8.1M |
| Symetrica | UK | 3 | €7.9M |
| Series B |
| €41M |
| 2022-06 |
| PhoreMost | Series B | €39M | 2024-09 |
| PetMedix | Series B | €31M | 2021-09 |
| GaN Devices | Series C | €30M | 2025-02 |
| Phasecraft | Series B | €29M | 2025-09 |
| AccelerComm | Series B | €25M | 2023-05 |
| Brainomix | Other | €20M | 2018-12 |
